From 1,085 citations identified, 48 studies with 15,368 men with mCRPC met inclusion criteria. Most studies were retrospective cohorts (n = 39) from Europe (n = 22) and North America (n = 18), with ...

SAN FRANCISCO -- Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when ...

Barry Goy, MD, provides insight into the clinical implications of a retrospective analysis examining 15-year outcomes in patients with intermediate-risk prostate cancer.

Fantastic fundraising” efforts were hailed when NHS staff joined campaigners to celebrate the success of an appeal which will revolutionise ...

Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk ...

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for patients with stage 3 or 4 kidney cancer, who face high recurrence risk.

The Decipher Bladder Genomic Subtyping Classifier found that patients with luminal tumors may have less aggressive disease.

WYFF News 4's Nigel Robertson has spent more than two decades at WYFF and recently shared his cancer journey after a ...

As you navigate the challenges of prostate cancer and erectile dysfunction, remember that you are not alone. With advances in ...

St. Bernards Medical Center is changing the game in treating prostate cancer with its new non-invasive treatment.

When prostate cancer metastasizes, spreads outside of the prostate itself, it typically affects the structures in its immediate vicinity. Structures near the prostate likely to be involved include ...